Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Here’s what to know before the market opens Thursday

    August 13, 2026

    Democrats demand Trump reveal stock managers, explain certain trades

    August 13, 2026

    Researchers found a way to hijack devices through Zoom screen sharing

    August 13, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Investing»Why is Kemira stock plunging today? By Investing.com
    Investing

    Why is Kemira stock plunging today? By Investing.com

    franperez66q@protonmail.comBy franperez66q@protonmail.comJune 10, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email



    Investing.com — stock is down 7.3% during today’s session after the Finnish chemicals company issued a profit warning and lowered its 2026 profitability outlook, citing higher raw material and logistics costs linked to the prolonged conflict in Iran.

    The company now expects 2026 revenue of €2.6 billion to €3.0 billion and operative EBITDA of €400 million to €500 million.

    As a result, the stock touched a new 52-week low of €15.29 intraday as persistent selling pressure from today’s news as well as a weak Q1 2026 earnings report continues to erode investor confidence in the Finnish specialty chemicals company.

    The April 24 interim results revealed that first-quarter EPS of €0.29 missed the consensus estimate of approximately €0.32, while revenue fell 4% year-on-year to €677.3 million and operative EBITDA dropped 13% to €117.3 million — with the margin shrinking to 17.3% from 19.1% in the prior-year period.

    CEO Antti Salminen described the quarter as dominated by a “really weak global economy” and escalating geopolitical tensions that created strong headwinds across the business, particularly in the Packaging & Hygiene Solutions segment, where the operative EBITDA margin compressed to 10.1% from 12.0%. Adding to the pressure, analysts have been trimming their price targets in the aftermath of the results, with Danske Bank issuing a downgrade and the consensus target declining from €22.65 to €21.80, reflecting more cautious assumptions on revenue growth and profit margins going forward.

    The broader market context offers little relief, with the NASDAQ declining and the S&P 500 also trading in negative territory today, reinforcing a risk-off tone that tends to disproportionately affect mid-cap industrial and specialty chemicals names.

    Kemira’s full-year 2026 guidance — with a wide revenue range of €2,600–€3,000 million and operative EBITDA of €470–€570 million — has itself been interpreted as a signal of significant uncertainty, as the company also flagged that raw material cost increases (particularly oil derivatives, which represent roughly one-third of its cost base) and ongoing foreign exchange headwinds could further pressure margins.

    The combination of a meaningful earnings miss, deteriorating segment profitability, analyst downgrades, elevated input costs, and a cautious macro environment has created a compounding negative feedback loop for Kemira shares today, pushing the stock to levels not seen in over a year and raising questions about whether the company can return to its operative EBITDA margin target range of 18–21% on a quarterly basis in the near term.

    This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Russia stocks higher at close of trade; MOEX Russia Index up 0.75%

    August 2, 2026

    AstraZeneca and Bristol-Myers Squibb in talks over potential merger – Report

    August 2, 2026

    AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports By Reuters

    August 2, 2026

    Is now the time to buy European equities?

    August 2, 2026

    Saudi Arabia stocks higher at close of trade; Tadawul All Share up 1.10%

    August 2, 2026

    For GLP-1 users, the in-store clothes shopping trip is back

    August 2, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    Here’s what to know before the market opens Thursday

    August 13, 2026

    Democrats demand Trump reveal stock managers, explain certain trades

    August 13, 2026

    Researchers found a way to hijack devices through Zoom screen sharing

    August 13, 2026

    Birmingham Green Party councillor charged with assaulting five people

    August 13, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.